JCXH-105

N/A

Report date: 2026/05/13 09:17:17

Base Information

Drug NameJCXH-105
Drug Alias Nameself-amplifying mRNA vaccine JCXH-105自复制RNA带状疱疹疫苗（JCXH-105注射液）JCXH-105
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > self-amplifying RNA vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHerpes ZosterCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesImmorna (Hangzhou) Biotechnology Co., Ltd
China Registration ClassN/A

Develop Information

Active CompaniesImmorna Biotherapeutics IncImmorna (Hangzhou) Biotechnology Co., Ltd
Inactive CompaniesN/A
Active IndicationsHerpes ZosterCommunicable Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A